4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0000950170-25-038878
Chief Financial Officer bought 10,000 shares at an average $10.10 ($100,988)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ignelzi Troy A. Chief Financial Officer | 2025-03-12 | Purchase | +9,900 | $10.10 | $99,990 | 9,900 | D |
| Ignelzi Troy A. Chief Financial Officer | 2025-03-13 | Purchase | +100 | $9.98 | $998 | 10,000 | D |
| Open-market purchases · 10,000 sh · avg $10.10 · $100,988 | |||||||
Loading xslF345X05/ownership.xml…